REDEFINING ATRIAL FIBRILLATION MANAGEMENT: PERSPECTIVES FOR 2023 GUIDELINES

• DOI: https://doi.org/10.22533/at.ed.1594602426063

• Palavras-chave: Fibrillation, Atrial; Management; Guidelines.

• Keywords: Fibrillation, Atrial; Management; Guidelines.

• Abstract:

  Objective: Analyze the main 2023 updates for the management of atrial fibrillation (AF) and their impact on clinical practice. Methods: Literature review through searches in the PubMed - MEDLINE (Medical Literature Analysis and Retrieval System Online) databases through the research strategy (Atrial Fibrillation) AND (Management) AND (2023) AND ((Update) OR (Guidelines)). After applying the inclusion and exclusion criteria, 17 articles were selected to form the collection of this study. Review: The identification of AF through routine screening, as well as the management of risk factors and comorbidities have become a pillar in its treatment. Rhythm and frequency control strategies are effective approaches and objects of wide debate, highlighting the importance of choosing a personalized treatment for each patient. The need for anticoagulant therapy can be assessed using the CHA2DS2-VASc score, with direct oral anticoagulants (NOAC's) currently being preferred in those who qualify for their use. Final Considerations: Catheter ablation is shown to be first-line therapy in a select group of patients with left ventricular dysfunction improving cardiovascular outcomes and survival. It is notable that, given constant updates in the area, continuing medical education becomes essential to guarantee a high standard of care for patients.